Skip to main content

Cultivating Passion for Innovation and Connection: BioHouston CEO Ann Tanabe

Published Nov 05, 2020 by Lou Ann Duvall

Ann BioHouston

The global life science community is coming together for a virtual event next week that will explore the latest advances within the industry. The Texas Life Science Forum brings together industry professionals, emerging life science companies, academics, investors and thought leaders. The event is co-hosted by Rice University and BioHouston, a nonprofit organization founded by Houston-area academic and research institutions. Their mission is to generate economic wealth for Houston by establishing the region as a global competitor in life science and biotechnology commercialization. 

Ann Tanabe, BioHouston's CEO, said she has a passion for working with innovators. Earlier in her career, Tanabe worked in investor relations with publicly traded companies, including energy and pharmaceuticals. She joined BioHouston nine years ago. 

"Our work benefits the community by advancing the life sciences industry in Houston," said Tanabe. "We serve to connect scientists, intellectual property and product development experts, venture capitalists, pharmaceutical companies and life sciences entrepreneurs."

We asked Tanabe about how BioHouston drives life science innovation forward by connecting people to resources, talent and information. 

How have you seen the life sciences ecosystem in Houston change over the last few years? 

We are fortunate to be in the Texas Medical Center, with its academic and research work that revolves around innovation. More people are recognizing Houston for its opportunities to work in a broad range of life sciences roles. Bright young people are choosing to come to Houston for its great academic institutions, and they’re staying after graduation because they see opportunities to be game-changers in the life sciences arena. 

It’s a capital-intensive industry, and investors want to see that strong ecosystem and talent. They’re taking notice of what’s happening here. To have a fully-rounded ecosystem, you need companies at every point along the spectrum: start-ups, clinical stage, and industry veterans. We have all of that. 

What has BioHouston’s role been in the evolving ecosystem? 

We’re like the information booth at the airport. We are a hub that connects people and organizations, including scientists, intellectual property and product development experts, venture capitalists, pharmaceutical companies, and others seeking opportunities in life sciences. 

We direct people to the resources they need, whether that’s in patient care, research or innovation. BioHouston is community-driven and not connected to any one institution. We offer an efficient way to learn about what resources and opportunities exist.

BioHouston does talent matchmaking, helping companies find newly-minted grads, for example. We can connect start-ups with accelerator programs, office or lab space. Insurance companies, banks, payroll companies and lab supply sellers come to us for introductions when they are looking for business development opportunities in the life sciences community. 

How do you think COVID-19 will affect the life sciences ecosystem? 

I think it’s been interesting to see how COVID has reshaped and reframed how people interact. So much U.S. life sciences activity is based on the east and west coasts. But now, location isn’t a factor. A venture capitalist can do a Zoom call, or a top scientist can present at our virtual Texas Life Sciences Forum – without leaving home. As we all get more comfortable with virtual technology platforms, Houston’s life sciences ecosystem will benefit.  

We have several Houston area contract manufacturers producing SARS-CoV-2 vaccines for multiple pharma companies. We also have several local companies developing their own novel COVID-19-related treatments. And of course, on the patient care side, the Texas Medical Center has played a tremendous role during the pandemic. We will continue to see great leadership from TMC and our local academic and research institutions.

How can members of the business community support BioHouston?

Because of the pandemic and limits on bringing people together, we have had to reschedule two events the business community may recognize – our Women in Science with Excellence (WISE) event and our Chili Cook-off. So watch for news about those events in 2021. We welcome new members and community partners to join our ranks. We also invite business leaders to follow BioHouston on LinkedIn, to stay abreast of our work in the community.

Learn more about Houston's life science industry. 

Related News

Health Care

Texas Children’s Hospital, MD Anderson Cancer Center Announce Joint Venture Dedicated to Pediatric Cancer Care

2/21/25
Texas Children’s Hospital and the University of Texas MD Anderson Cancer Center have announced a new joint venture aimed at advancing pediatric cancer treatment.   According to the U.S. Census Bureau, more than 24 percent of Texas' population is under 18 years old, and Texas Oncology reports that over 1,700 children under the age of 20 are diagnosed with cancer, with nearly 200 losing their lives to the disease annually. This makes the need for life-saving treatments more crucial than ever.  By combining the expertise and resources of two of the nation’s leading medical institutions, the partnership will expand access to clinical trials, catalyzing innovative discoveries that can bring treatments to young patients faster.  “The scope and scale of our combined effort will build the world’s preeminent pediatric cancer center, addressing the growing need for excellent patient care and greatly benefiting children with cancer through increased access to care and to clinical trials,” Dr. Peter WT Pisters, president of MD Anderson, said in a press release. “MD Anderson and Texas Children’s offer unique strengths that when brought together will accelerate improved outcomes for patients in Texas and around the world.”  Set to launch in early 2026, the joint venture will prioritize the creation of new facilities designed to enhance the overall patient experience, featuring state-of-the-art medical technology and a “best-in-class healing environment.”  The care team will include 200 Texas Children’s pediatric oncology specialists who are full-time faculty with Baylor College of Medicine and more than 100 MD Anderson pediatric clinicians and researchers.  “This groundbreaking collaboration between two proven leaders in pediatric and cancer care marks the beginning of a new era in the fight against childhood cancer,” Debra Sukin, president and chief executive officer of Texas Children’s, said in the release. “The combined force of our two iconic programs will be led with the nation’s top talent—from clinicians and researchers to nurses and administrative professionals—each committed to realizing the shared mission of eradicating pediatric cancer.”  The initiative will also invest in pediatric oncology education programs, ensuring that the next generation of medical professionals is equipped with the tools and knowledge needed to continue advancing pediatric cancer treatment.  The partnership between Texas Children’s and MD Anderson showcases Houston’s dedication to advancing cancer research and pioneering life-saving treatments. In line with this commitment, MD Anderson furthered its efforts last year through a partnership with Rice University to establish the Cancer Bioengineering Collaborative. This collaboration focuses on both fundamental and translational cancer research, developing cutting-edge technologies for cancer detection and therapy, and securing external funding to support continued research and training.  Learn more about Houston’s life sciences ecosystem. 
Read More
Health Care

United Imaging Announces Major Expansion of U.S. Manufacturing Space

2/6/25
[PRESS RELEASE Provided by United Imaging] January 9, 2025 -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, has signed on for additional production and office space in greater Houston. The new space in Pearland, Texas will more than triple the total size of the company's current manufacturing square footage that's now at their North American headquarters on Kirby Drive. It was only just over four years ago that the company opened that current production facility.    United Imaging has been steadily increasing U.S. production since then, with products in all four imaging modalities it currently sells achieving local production in Texas over the last four years. All critical spare parts are already stored in Houston and in stocking locations across the country.  "With the steadily spiking demand and manufacturing capacity also has come an increase in hiring" said Jeffrey M. Bundy, PhD, CEO of United Imaging Healthcare North America. Since 2021, U.S. headcount growth has averaged 60% annually.  The proximity to Houston's ports provides strategic opportunity the global company has been investing in for years, with increasing operations in South America and across the world. United imaging also announced recently its first product registrations in Canada. It has installations in 75+ countries worldwide since 2011, and earlier this summer announced its 30,000th unit installed globally, which was in the U.S.  At United Imaging, we develop and manufacture advanced medical products, digital healthcare solutions, and intelligent solutions that cover the entire process of imaging diagnosis and treatment. Founded in 2011, our company has subsidiaries and R&D centers across the world. Our North American headquarters in Houston includes our corporate offices, factory, product showroom, service training center, and service parts distribution center. With a cutting-edge digital portfolio and a mission of Equal Healthcare for All™, we help drive industry progress and bold change. To learn more, visit united-imaging.com or follow us on LinkedIn and Twitter @UnitedImagingHC. 
Read More

Related Events

Health Care

The Future of Health Care: Thought Leader Series

Health care is at a pivotal moment, and Houston—home to the world’s largest medical complex—is at the forefront of innovation, policy, and systemic change. Join us for The Future of Health Care: A Thought Leader…

Learn More
Learn More
Executive Partners